Advertisement

Topics

Merck-Aktie: Super Long-Chance! Chartanalyse

04:34 EDT 22 Jun 2017 | FinanzNachrichten

Lauda-Königshofen - Merck-Aktie: Super Long-Chance! Chartanalyse Noch vor wenigen Wochen markierte das Papier von Merck (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol: MRK, Nasdaq OTC-Symbol: MKGA...

Original Article: Merck-Aktie: Super Long-Chance! Chartanalyse

NEXT ARTICLE

More From BioPortfolio on "Merck-Aktie: Super Long-Chance! Chartanalyse"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...